Brief: Bergenbio Q1 Operating Loss Narrows To NOK 78.6 Million

Oncoinvent ASA

24/05/2022 06:18

May 24 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO ASA: RESULTS FOR THE FIRST QUARTER 2022
    * Q1 TOTAL OPERATING EXPENSES FOR Q1 WERE NOK 78.6 MILLION
(NOK
83.4 MILLION)
    * Q1 OPERATING LOSS FOR Q1 CAME TO NOK 78.6 MILLION

Source text for Eikon:  ID:nWkr8K2W2r 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))